#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurofibromatosis Liver transplant rejection Testicular leiomyosarcoma Bulbospinal muscular atrophy congenital Pouchitis Myotonic dystrophy Infection in an immunocompromised host Congenital nephrogenic diabetes insipidus Lung adenocarcinoma Congenital ectodermal dysplasia Oesophageal adenocarcinoma Immune thrombocytopenia Hodgkin's disease Sarcoidosis Glioma More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I Malignant fibrous histiocytoma Pulmonary fibrosis – Basic Information Crigler-Najjar syndrome – Treatment Hepatic angiosarcoma – Trials in Disease Immunodeficiency congenital – Trials in Disease Acute respiratory distress syndrome – Basic Information Ornithine transcarbamoylase deficiency – Trials in Disease Tuberous sclerosis complex – Trials in Disease Soft tissue sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Envudeucitinib Trazodone Sebetralstat GSKVX000000048110 Mecasermin Rinfabate Volixibat Cefotaxime Phenylephrine Tas3351 Bifikafusp Alfa Relugolix Ferric Carboxymaltose Mesenchymal Cells Zanamivir Emactuzumab Tacrolimus Molgramostim ATIGOTATUG Art0380 Mesilate Methylprednisolone Aceponate More therapies…

    Learn about Your Condition

    Neurodevelopmental disorder Follicular lymphoma Spinal osteoarthritis Guttate psoriasis Thalassaemia beta Acquired ATTR amyloidosis Cervix carcinoma recurrent Large cell lung cancer Primary hypogonadism Nodular melanoma Malignant oligodendroglioma Hepatocellular carcinoma Wolfram syndrome Paraesthesia Metabolic surgery More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune system processes

  • Study on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • Ipilimumab
    • Atezolizumab
    • Bevacizumab
    France

  • Study on Long-term Safety of Ustekinumab for Children with Crohn’s Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Ustekinumab
    Belgium France Germany Hungary Italy Poland +1

  • Study on the Effects of GLPG3667 for Adults with Dermatomyositis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatomyositis
    Investigated Drugs:
    • Glpg3667 Fumarate
    Belgium Bulgaria Croatia Czechia France Germany +4

  • Study on Preventing BK Virus Infection in Kidney Transplant Patients Using Mycophenolic Acid, Mycophenolate Mofetil, and Sirolimus

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Complications of transplanted kidney
    Investigated Drugs:
    • Sirolimus
    • Mycophenolic Acid
    • Mycophenolate Mofetil
    Spain

  • Study on Capecitabine and Durvalumab for Patients with Removed Biliary Tract Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Bile duct cancer
    Investigated Drugs:
    • Capecitabine
    • Durvalumab
    France

  • Study on Cognitive Function in Liver Transplant Patients Comparing Once-Daily and Twice-Daily Tacrolimus Formulations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Liver transplant
    Investigated Drugs:
    • Tacrolimus
    Germany
Previous Page
1 … 12 13 14 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!